Oncology news

21-07-2016 | Breast cancer | Highlight | Article
Editor's pick

Breast cancer risk reassurance for IVF-treated women

Women who receive in vitro fertilisation treatment do not have a higher risk of developing breast cancer in the long term versus those who receive non-IVF therapy and the general population, say Dutch researchers.


JAMA 2016; 316: 300–312

22-07-2016 | Chronic myeloid leukaemia | News | Article

Long-term dasatinib supported in CML

Dasatinib has durable efficacy and manageable toxicity in the long-term treatment of patients with chronic-phase chronic myeloid leukaemia that is resistant or intolerant to imatinib, shows final analysis of the CA180-034 trial.


Am J Hematol 2016; Advance online publication

22-07-2016 | Chronic myeloid leukaemia | News | Article

TKI therapy shows ‘excellent efficacy’ in Japanese CML population

A review of tyrosine kinase inhibitor therapy in Japanese patients with chronic myeloid leukaemia demonstrates high rates of treatment response and good outcomes but highlights the various issues associated with treatment discontinuation.


J Clin Exp Hematop 2016; 56: 34–42

22-07-2016 | Chronic myeloid leukaemia | News | Article

‘Dramatic’ increase seen in CML life expectancy

Patients with chronic myeloid leukaemia can now expect to live almost as long as members of the general population, say researchers.


J Clin Oncol 2016; Advance online publication

20-07-2016 | Colorectal cancer | News | Article
News in brief

Postdiagnosis omega-3 intake may lower CRC mortality

Increasing intake of marine omega-3 polyunsaturated fatty acids after diagnosis could provide a colorectal cancer-related mortality benefit.

Real-World Paclitaxel–Bevacizumab Results Reported For HER2-Negative Metastatic Breast Cancer

Analysis of French patients treated for HER2-negative metastatic breast cancer indicates the possibility of a survival benefit for paclitaxel plus bevacizumab over paclitaxel alone

Read the full story on ESMO's oncologyPRO educational website (for registered ESMO members).

approvalsWatch: Oncology



medwireNews brings you coverage of the 2015 European Cancer Congress, held in Vienna, Austria.

Click through to read the full reports of the latest research.

Twitter Icon Follow medwireNews

Click here
image credits